Intersect ENT Inc. (NASDAQ:XENT) on Wednesday reported a loss of $5.8 million in its second quarter. The Menlo Park, California-based company said it had a loss of 23 cents per share. The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share. Intersect ENT, Inc. (NASDAQ:XENT) belongs to Healthcare sector. Its net profit margin is -43.40% and weekly performance is -5.15%. On last trading day company shares ended up $28.00. Intersect ENT, Inc. (NASDAQ:XENT) distance from 50-day simple moving average (SMA50) is -3.20%.
Morgan Stanley (NYSE:MS) said on Wednesday it has raised $1.7 billion for its eighth direct investment real estate fund. The fund, called North Haven Real Estate Fund VIII Global, has already made investments in the United States, U.K., Austria, Japan and Australia. Morgan Stanley (NYSE:MS) shares moved down -0.18% in last trading session and ended the day at $38.93. MS Gross Margin is 87.10% and its return on assets is 0.50%. Morgan Stanley (NYSE:MS) quarterly performance is 4.10%.
BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) announced that Robert A. Ingram was elected to the Company’s Board of Directors. On 06 August, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares moved down -4.10% and was closed at $14.27. BCRX EPS growth in last 5 year was -14.20%. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) year to date (YTD) performance is 17.35%.
Select Comfort Corporation (NASDAQ:SCSS) ended the last trading day at $25.83. Company weekly volatility is calculated as 2.22% and price to cash ratio as 15.26. Select Comfort Corporation (NASDAQ:SCSS) showed a weekly performance of 0.47%.
On 4 August, Vringo, Inc. (NASDAQ:VRNG) reported net loss from continuing operations was approximately $8.5 million (including non-cash expenses) for the quarter ended June 30, 2015. Vringo, Inc. (NASDAQ:VRNG) shares advanced 1.26% in last trading session and ended the day at $0.64. VRNG return on assets is -138.00%. Vringo, Inc. (NASDAQ:VRNG) quarterly performance is -5.42%.